Committee 2
Doses From Radiation Exposure

Committee 2 is concerned with the development of dose coefficients for the assessment of internal and external radiation exposure; development of reference biokinetic and dosimetric models; and reference data for workers and members of the public.

Back Row(L-R): Chan Hyeong Kim (South Korea), Frank Wissman (Germany), Derek Jokisch (United States), Alexander Ulanowski (Austria), Augusto Giussani (Germany), Wesley Bolch (Secretary, Uniteds States), Tatsuhiko Sato (Japan)
Front Row(L-R): Francois Paquet (Vice Chair, France), Maria Antonia Lopez (Spain), Eric Blanchardon (France), Nina Petoussi-Henss (Germany), John Harrison (Chair, United Kingdom), Volodymyr Berkovskyy (Ukraine), Rich Leggett (United States), Tracy Smith (United Kingdom), Junli Li (China)

Summaries of Committee 2 Meetings:

John D. Harrison (Chair), Oxford Brookes University and Public Health England, UK
Francois Paquet (Vice-Chair), French Institute for Radiological Protection and Nuclear Safety (IRSN), France
Wesley E. Bolch (Secretary), University of Florida, USA
Volodymyr Berkovskyy (Member), Ukrainian Radiation Protection Institute (RPI) and National Research Center for Radiation Medicine (NRCRM), Ukraine
Eric Blanchardon (Member), French Institute for Radiological Protection and Nuclear Safety (IRSN), France
Augusto Giussani (Member), Federal Office for Radiation Protection (BfS), Germany
Derek Jokisch (Member), Francis Marion University, USA
Chan Hyeong Kim (Member), Hanyang University, Korea
Rich Leggett (Member), Oak Ridge National Laboratory (ORNL), USA
Junli Li (Member), Tsinghua University, China
Maria Antonia Lopez (Member), CIEMAT, Spain
Nina Petoussi-Henss (Member), Helmholtz Zentrum München, Germany
Tatsuhiko Sato (Member), Japan Atomic Energy Agency (JAEA), Japan
Tracy Smith (Member), Public Health England, UK
Alexander Ulanowski (Member), International Atomic Energy Agency, Austria
Frank Wissmann (Member), Federal Office for Radiation Protection, Germany

Active Task Groups under Committee 2

Task Group 36
Radiation Dose to Patients from Radiopharmaceuticals
Task Group 79
The Use of Effective Dose as a Risk Related Radiological Protection Quantity
Task Group 90
Age-dependent Dose Conversion Coefficients for External Exposures to Environmental Sources
Task Group 95
Internal Dose Coefficients
Task Group 96
Computational Phantoms and Radiation Transport
Task Group 103
Mesh-type Reference Computational Phantoms (MRCP)